Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise
dc.authorscopusid | 22633521000 | |
dc.authorscopusid | 55872112400 | |
dc.authorscopusid | 57209188029 | |
dc.authorscopusid | 6508102640 | |
dc.authorscopusid | 55981133400 | |
dc.authorscopusid | 7401856702 | |
dc.authorscopusid | 9243496300 | |
dc.contributor.author | Aydin S.Z. | |
dc.contributor.author | Direskeneli H. | |
dc.contributor.author | Merkel P.A. | |
dc.contributor.author | Toloza S. | |
dc.contributor.author | Blockmans D. | |
dc.contributor.author | Sato E.I. | |
dc.contributor.author | De Souza A.W.S. | |
dc.date.accessioned | 2024-06-12T10:26:10Z | |
dc.date.available | 2024-06-12T10:26:10Z | |
dc.date.issued | 2017 | |
dc.description.abstract | Objective. To arrive at consensus for candidate outcomes for disease activity assessment in largevessel vasculitis (LVV) in clinical trials. Methods.A Delphi survey including 99 items was circulated among international experts for 3 rounds. Results. Fifty-seven items were accepted for both giant cell arteritis and Takayasu arteritis. Sixty-seven percent of experts voted to have a common approach for both diseases with additional disease-specific items such as weight loss, scalp tenderness/necrosis, morning stiffness, dizziness, visual symptoms, and imaging. Conclusion. This study highlights similarities and differences in experts' perspectives for assessing clinical activity in LVV and may guide a consensus-driven core set of validated outcomes. Copyright © 2017. All rights reserved. | en_US |
dc.description.sponsorship | National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIAMS: U01 AR51874 04, U54AR057319; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIAMS; National Center for Research Resources, NCRR: U54 RR019497; National Center for Research Resources, NCRR; Vasculitis Clinical Research Consortium, VCRC | en_US |
dc.description.sponsorship | Sponsored by the Vasculitis Clinical Research Consortium, which has received support from the US National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54 AR057319 and U01 AR51874 04), the National Center for Research Resources (U54 RR019497), and the Office of Rare Diseases Research. Additional support for the work of the OMERACT Vasculitis Working Group was received through a Patient-Centered Outcomes Research Institute Pilot Project Grant. S.Z. Aydin, MD, Associate Professor, Division of Rheumatology, The Ottawa Hospital Research Institute, University of Ottawa; H. Direskeneli, MD, Professor of Rheumatology, Division of Rheumatology, Marmara University Faculty of Medicine; P.A. Merkel, MD, MPH, Professor of Medicine and Epidemiology, Division of Rheumatology, and Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania. Address correspondence to Dr. P.A. Merkel, Section of Rheumatology, University of Pennsylvania, White Building, 5th Floor Penn, 3400 Spruce St., Philadelphia, Pennsylvania 19104, USA. E-mail: pmerkel@upenn.edu Accepted for publication June 3, 2017. | en_US |
dc.identifier.doi | 10.3899/jrheum.161269 | |
dc.identifier.endpage | 1932 | en_US |
dc.identifier.issn | 0315-162X | |
dc.identifier.issue | 12 | en_US |
dc.identifier.pmid | 28864648 | en_US |
dc.identifier.scopus | 2-s2.0-85037094161 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 1928 | en_US |
dc.identifier.uri | https://doi.org/10.3899/jrheum.161269 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/16684 | |
dc.identifier.volume | 44 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Journal of Rheumatology | en_US |
dc.relation.ispartof | Journal of Rheumatology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Giant Cell Arteritis; Large Vessel; Outcomes; Takayasu Arteritis; Vasculitis | en_US |
dc.subject | Aortic Arch Syndrome; Article; Blood Vessel Diameter; Clinical Outcome; Consensus; Delphi Study; Disease Activity; Dizziness; Giant Cell Arteritis; Health Survey; Human; International Cooperation; Large Vessel Vasculitis; Medical Expert; Musculoskeletal Stiffness; Outcome Assessment; Priority Journal; Skin Necrosis; Vasculitis; Visual Disorder; Weight Reduction; Aortic Arch Syndrome; Giant Cell Arteritis; Severity Of Illness Index; Delphi Technique; Giant Cell Arteritis; Humans; Severity Of Illness Index; Takayasu Arteritis | en_US |
dc.title | Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise | en_US |
dc.type | Article | en_US |